M O'C, man, aged 49. History: In good health until 1953 when he complained of back pain. In 1959, the typical spinal changes of ankylosing spondylitis were seen on X-ray. In October 1960, chest X-ray revealed pulmonary apical fibrosis. The search for tubercle bacilli in sputum was repeatedly negative, and bronchoscopy was normal. There was no improve-*I ment clinically or radiologically following a twoyear course of antituberculous drugs. Further chest X-rays in 1965 showed cyst-like spaces in the lung apices. In 1968 he began to have hamoptyses and was dyspnoeic on exertion. A pulmonary ejection systolic murmur was audible. In 1971 he had a large himatemesis possibly related to aspirin or phenylbutazone ingestion. Barium meal and coeliac axis arteriography were normal. Hamatamesis continued and Polya partial gastrectomy was performed. No acute bleeding point was found and recovery was uneventful. Present symptoms are dyspnoea and intermittent small hemoptyses. Not taking any drugs. On examination: Thin, kyphotic. Chest expansion 1.25 cm. No spinal mobility. Bronchial breathing at both apices. Loud systolic murmur in pulmonary area. Investigations: Hb 13.6 g/100 ml, WBC 8000/mm3, ESR 69 mm in 1 hour (Westergren). Chest X-ray shows shrunken fibrotic upper lobes with a mycetoma in the right apical cavity (Figs 1 and 2) . He has strongly positive precipitating antibodies to Aspergillusfumigatus. Skin tests to this fungus are negative. Spinal X-rays show advanced changes of ankylosing spondylitis. Respiratory function tests show total lung capacity of 3.1 litres (predicted 6.2), FEV1 1.3 litres (predicted 3.2), VC 1.3 litres (predicted 4.2), arterial Po2 85 mmHg, arterial Pco2 55 mmHg, arterial pH 7.30, transfer factor (single breath method) 14 ml per min per mmHg (predicted 27).
Discussion
The first description of the association of ankylosing spondylitis and nontuberculous pulmonary fibrosis was made by Hamilton (1949) . A review of this association by Davies (1972) , revealed that there were over 50 case reports and Davies, himself, added a further 7 patients. The pulmonary fibrosis commences in long-standing spondylitics with the onset of cough, sputum, and dyspncea. A diffuse mottling is seen in the upper zones of the lung fields which eventually progresses to dense fibrosis of the upper lobes, cavity formation, and bronchiectasis. Pleural thickening occurs over the involved areas. Haemoptyses are common, especially so with the development of aspergillomas in the lung cavities. These patients, not surprisingly, are often misdiagnosed as suffering from pulmonary tuberculosis, but, as in this patient, antituberculous drugs are ineffective. There is probably no special predisposition to pulmonary tuberculosis in ankylosing spondylitis (Wilkinson & Bywaters 1958 , Zorab 1962 , Hart et al. 1963 ) and there is no evidence that patients with -nontuberculous fibrosis are more liable to develop tuberculosis (Davies 1972).
Histological examination of nontuberculous pulmonary fibrosis reveals non-specific histological features. The alveolar walls are thickened, with interstitial fibrosis; occasionally giant cells of foreign body type are seen, and large numbers of histiocytes may be found in the alveoli; there is no evidence of a vasculitis (M 0 Skelton 1973, personal communication). There is at present no effective treatment.
